Furthermore, having antimicrobial, immunomodulatory, nephroprotective, cardioprotective, neuroprotective, anti-aging, anti-inflammatory, and anticancer actions are among its pharmacological characteristics of Spirulina sp
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group
It is important to note that there are currently some negative results of ASK1-related small molecule inhibitors (such as CFLAR-mimicking peptide) in clinical trials